Michael Lahn, CMO

Michael Lahn

Michael holds a MD in Medical Microbiology from the University of Mainz. He has over 20 years’ experience in oncology clinical development in the pharmaceutical industry, where he was responsible for the development of multiple molecules through early and late clinical development.

By building on complementary mechanisms between cancer and fibrosis iOnctura further aims to address high unmet need in fibrotic disease.